Back
ESC2025 Premium Access

Phenotypes of heart failure with preserved ejection fraction and effect of sodium-glucose cotransporter 2 inhibitors treatment

Session: Heart failure management in specific populations
Topic: Pharmacotherapy
Speaker: Mrs A. Sezaki (Tokyo, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mrs Ayano Sezaki

Nippon Medical School Hospital, Tokyo (Japan)
0 follower

9 more presentations in this session

Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population

Speaker: Doctor J. Noiri (Kobe, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

The relevant role of frailty in patients with transthyretin amyloidosis cardiomyopathy

Speaker: Doctor B. Dal Passo (Ferrara, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Role of comorbidities and weight variations in the survival of diabetic patients with heart failure

Speaker: Professor O. Hanon (Paris, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Angiotensin receptor-neprilysin inhibitor-based therapy among adult heart failure patients with below normal systemic ventricular ejection fraction and complex congenital heart disease

Speaker: Doctor D. Dela Cruz (Metro Manila, PH)

Access
Abstract
Slides
Video
Like
Thumbnail

The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a systematic review

Speaker: Doctor M. Hunjul (Nablus, PS)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Heart failure management in specific populations

Speakers: Mrs A. Sezaki, Doctor J. Noiri, Doctor B. Dal Passo, Professor O. Hanon, Doctor D. Dela Cruz...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources